Swiss National Bank’s Abiomed Inc ABMD Stock Holding History

Swiss National Bank’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-197,314	Closed	-$48.5M	–	2770
2022 Q3	$48.5M	Buy	197,314 +200	+0.1%	+$54K	0.03%	456
2022 Q2	$48.8M	Buy	197,114 +100	+0.1%	+$27K	0.03%	477
2022 Q1	$65.3M	Buy	197,014 +24,500	+14%	+$7.54M	0.04%	443
2021 Q4	$62M	Sell	172,514 -7,000	-4%	-$2.37M	0.04%	441
2021 Q3	$58.4M	Sell	179,514 -5,000	-3%	-$1.69M	0.04%	446
2021 Q2	$57.6M	Buy	184,514 +10,656	+6%	+$3.27M	0.04%	469
2021 Q1	$55.4M	Buy	173,858 +3,800	+2%	+$1.22M	0.04%	465
2020 Q4	$55.1M	Sell	170,058 -4,800	-3%	-$1.33M	0.04%	448
2020 Q3	$48.4M	Sell	174,858 -3,400	-2%	-$980K	0.04%	418
2020 Q2	$43.1M	Buy	178,258 +3,000	+2%	+$602K	0.04%	444
2020 Q1	$25.4M	Buy	175,258 +32,200	+23%	+$5.35M	0.03%	490
2019 Q4	$24.4M	Sell	143,058 -6,000	-4%	-$1.11M	0.03%	559
2019 Q3	$26.5M	Buy	149,058 +1,958	+1%	+$423K	0.03%	523
2019 Q2	$38.3M	Buy	147,100 +4,400	+3%	+$1.17M	0.04%	435
2019 Q1	$40.8M	Buy	142,700 +4,000	+3%	+$1.33M	0.04%	413
2018 Q4	$45.1M	Buy	138,700 +3,700	+3%	+$1.29M	0.06%	333
2018 Q3	$60.7M	Sell	135,000 -4,000	-3%	-$1.58M	0.07%	302
2018 Q2	$56.9M	Buy	139,000 +65,700	+90%	+$23.8M	0.07%	312
2018 Q1	$21.3M	Buy	73,300 +2,000	+3%	+$507K	0.03%	565
2017 Q4	$13.4M	Buy	71,300 +1,700	+2%	+$317K	0.01%	635
2017 Q3	$11.7M	Buy	69,600 +700	+1%	+$106K	0.01%	655
2017 Q2	$9.87M	Buy	68,900 +700	+1%	+$94.1K	0.01%	688
2017 Q1	$8.54M	Buy	68,200 +900	+1%	+$104K	0.01%	725
2016 Q4	$7.58M	Buy	67,300 +2,100	+3%	+$243K	0.01%	752
2016 Q3	$8.38M	Sell	65,200 -2,100	-3%	-$252K	0.01%	694
2016 Q2	$7.36M	Buy	67,300 +400	+0.6%	+$39.8K	0.01%	734
2016 Q1	$6.12M	Buy	66,900 +13,400	+25%	+$1.13M	0.01%	779
2015 Q4	$4.83M	Buy	53,500 +400	+0.8%	+$33.9K	0.01%	807
2015 Q3	$4.93M	Buy	53,100 +7,200	+16%	+$634K	0.01%	789
2015 Q2	$3.02M	Buy	45,900 +1,000	+2%	+$66.4K	0.01%	1058
2015 Q1	$3.21M	Buy	44,900 +700	+2%	+$38K	0.01%	1018
2014 Q4	$1.68M	Buy	44,200 +800	+2%	+$25.2K	0.01%	1381
2014 Q3	$1.08M	Hold	43,400	–	–	﹤0.01%	1621
2014 Q2	$1.09M	Hold	43,400	–	–	﹤0.01%	1677
2014 Q1	$1.13M	Buy	43,400 +9,900	+30%	+$274K	﹤0.01%	1630
2013 Q4	$896K	Hold	33,500	–	–	﹤0.01%	1599
2013 Q3	$639K	Sell	33,500 -1,500	-4%	-$34.3K	﹤0.01%	1779
2013 Q2	$755K	Buy	+35,000	New	+$703K	﹤0.01%	1620

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Swiss National Bank's ABMD Position: Q4 2022 in Review

Swiss National Bank sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 197,314 shares — an estimated $48.5M sold.

Swiss National Bank first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $65.3M in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Swiss National Bank reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Swiss National Bank sold 197,314 Abiomed Inc shares in Q4 2022, an estimated $48.5M.
Swiss National Bank first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
Swiss National Bank's Abiomed Inc position peaked at $65.3M in Q1 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Swiss National Bank's 13F filing for Q4 2022, filed 8 Feb 2023.